Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07607353
NA

Biodegradable Stents in Primary Sclerosing Cholangitis

Sponsor: King's College Hospital NHS Trust

View on ClinicalTrials.gov

Summary

In patients with PSC, endoscopic therapy of strictures aims to improve cholestasis by relieving the biliary obstruction via endoscopic biliary dilatation with consideration of plastic stents in strictures refractory to dilatation due to the risk of pancreatitis and cholangitis . Short term stents have been shown to have similar recurrence-free rates compared to dilatation in a randomised control trial; however, this was terminated after interim analysis due to higher rates of serious adverse events in the stent group. The long term benefits are unclear; however, it may lead to improved survival compared to predicted survival. In this group of patients with limited treatment options, biodegradable stents may provide an attractive additional treatment modality in the management of high grade strictures.

Official title: Pilot Study of Biodegradable STents in Primary Sclerosing Cholangitis - BSTPSC

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-03-01

Completion Date

2027-04-01

Last Updated

2026-05-29

Healthy Volunteers

No

Interventions

DEVICE

archimedes stent

archimedes stent for HGS

Locations (1)

King's College Hospital, London

London, United Kingdom